| Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements I Tanasi, I Ba, N Sirvent, T Braun, W Cuccuini, P Ballerini, N Duployez, ... Blood, The Journal of the American Society of Hematology 134 (16), 1351-1355, 2019 | 123 | 2019 |
| Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study JI Muñoz-González, I Álvarez-Twose, M Jara-Acevedo, R Zanotti, ... The Lancet Haematology 8 (3), e194-e204, 2021 | 55 | 2021 |
| Extracellular vesicle-dependent communication between mesenchymal stromal cells and immune effector cells R Bazzoni, P Takam Kamga, I Tanasi, M Krampera Frontiers in cell and developmental biology 8, 596079, 2020 | 55 | 2020 |
| The role of notch and wnt signaling in MSC communication in normal and leukemic bone marrow niche P Takam Kamga, R Bazzoni, G Dal Collo, A Cassaro, I Tanasi, ... Frontiers in cell and developmental biology 8, 599276, 2021 | 53 | 2021 |
| Oncogenic mutations of MYD88 and CD79B in diffuse large B-cell lymphoma and implications for clinical practice C Visco, I Tanasi, FM Quaglia, I Ferrarini, C Fraenza, M Krampera Cancers 12 (10), 2913, 2020 | 44 | 2020 |
| Notch signaling molecules as prognostic biomarkers for acute myeloid leukemia P Takam Kamga, GD Collo, F Resci, R Bazzoni, A Mercuri, FM Quaglia, ... Cancers 11 (12), 1958, 2019 | 30 | 2019 |
| Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry VE Kennedy, C Perkins, A Reiter, M Jawhar, J Lübke, HC Kluin-Nelemans, ... Blood advances 7 (9), 1713-1724, 2023 | 28 | 2023 |
| Bone marrow mastocytosis: a diagnostic challenge R Zanotti, I Tanasi, A Bernardelli, G Orsolini, P Bonadonna Journal of Clinical Medicine 10 (7), 1420, 2021 | 27 | 2021 |
| Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study M Cerrano, M Bonifacio, M Olivi, A Curti, M Malagola, M Dargenio, ... Haematologica 107 (4), 996, 2022 | 26 | 2022 |
| Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter … E De Bellis, S Imbergamo, A Candoni, A Liço, I Tanasi, E Mauro, F Mosna, ... Leukemia Research 114, 106803, 2022 | 23 | 2022 |
| A multidisciplinary diagnostic approach reveals a higher prevalence of indolent systemic mastocytosis: 15-years’ experience of the GISM network R Zanotti, M Bonifacio, C Isolan, I Tanasi, L Crosera, F Olivieri, G Orsolini, ... Cancers 13 (24), 6380, 2021 | 21 | 2021 |
| Systemic mastocytosis: multidisciplinary approach R Zanotti, I Tanasi, L Crosera, M Bonifacio, D Schena, G Orsolini, ... Mediterranean Journal of Hematology and Infectious Diseases 13 (1), 2021 | 19 | 2021 |
| The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population M Bonifacio, M Tiribelli, MC Miggiano, E Abruzzese, G Binotto, L Scaffidi, ... Cancer Medicine 10 (18), 6310-6316, 2021 | 16 | 2021 |
| Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis C Visco, F Pregnolato, I Ferrarini, B De Marco, V Bonuomo, E Sbisa, ... Critical Reviews in Oncology/Hematology 163, 103377, 2021 | 15 | 2021 |
| Small molecule inhibitors of microenvironmental Wnt/β-catenin signaling enhance the chemosensitivity of acute myeloid leukemia P Takam Kamga, G Dal Collo, A Cassaro, R Bazzoni, P Delfino, A Adamo, ... Cancers 12 (9), 2696, 2020 | 15 | 2020 |
| Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series. I Tanasi, M Bonifacio, M Pizzolato, F Irene Grifoni, M Sciumè, C Elena, ... British Journal of Haematology 193 (4), 2021 | 11 | 2021 |
| High-throughput analysis and functional interpretation of extracellular vesicle content in hematological malignancies I Tanasi, A Adamo, PT Kamga, R Bazzoni, M Krampera Computational and Structural Biotechnology Journal 18, 2670-2677, 2020 | 11 | 2020 |
| Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project G Coltro, E Sant'Antonio, GA Palumbo, F Mannelli, V De Stefano, ... Cancer Medicine 12 (7), 8166-8171, 2023 | 10 | 2023 |
| Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic … D Lazzarotto, I Tanasi, A Vitale, M Piccini, M Dargenio, F Giglio, ... Annals of Hematology 102 (5), 1099-1109, 2023 | 9 | 2023 |
| Update on the role and utility of extracellular vesicles in hematological malignancies R Bazzoni, I Tanasi, N Turazzi, M Krampera Stem Cells 40 (7), 619-629, 2022 | 9 | 2022 |
